Menu
Recruiting NCT04499885

Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning

No phase Interventional Toxicity, Drug

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Paraffin oil gastric lavage, Gastric lavage with saline and sodium bicarbonate 8.4%.
Who it may be relevant to
Registry conditions: Toxicity, Drug. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial

Overview

Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning.

Detailed description

The study aims to investigate the Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial

Interventions

  • Device Paraffin oil gastric lavage
    Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution
  • Device Gastric lavage with saline and sodium bicarbonate 8.4%
    Gastric lavage with saline and sodium bicarbonate 8.4%

Primary outcome measures

  • Number of deaths [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • • Patients with symptomatic acute aluminum phosphide poisoning

Exclusion criteria

  • • Pregnant and lactating women
  • Asymptomatic patients with history of acute aluminum phosphide exposure.
  • Patients with ingestion or exposure to other substances in addition to aluminum phosphide.
  • Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).
  • Patients with previous medical intervention (had gastric lavage in any medical center before admission).
  • Patients with disturbed consciousness level
  • Patients with post cardiac arrest cases

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sherief Abd-Elsalam — Tanta

Identifiers

NCT: NCT04499885 · ghada protocol

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗